BEMAX
Price
$11.38
Change
+$0.07 (+0.62%)
Updated
Oct 3 closing price
Net Assets
835.41M
VEIEX
Price
$34.65
Change
+$0.09 (+0.26%)
Updated
Oct 3 closing price
Net Assets
130.49B
Interact to see
Advertisement

BEMAX vs VEIEX

Header iconBEMAX vs VEIEX Comparison
Open Charts BEMAX vs VEIEXBanner chart's image
Brandes Emerging Markets Value A
Price$11.38
Change+$0.07 (+0.62%)
VolumeN/A
Net Assets835.41M
Vanguard Emerging Mkts Stock Idx I
Price$34.65
Change+$0.09 (+0.26%)
VolumeN/A
Net Assets130.49B
BEMAX vs VEIEX Comparison Chart in %
View a ticker or compare two or three
VS
BEMAX vs. VEIEX commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEMAX is a StrongBuy and VEIEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 130B vs. BEMAX (835M). VEIEX pays higher dividends than BEMAX: VEIEX (2.64) vs BEMAX (2.38). BEMAX was incepted earlier than VEIEX: BEMAX (15 years) vs VEIEX (31 years). BEMAX (1.32) is less costly to investors than VEIEX (0.29). BEMAX is a more actively managed with annual turnover of: 21.13 vs. VEIEX (8.00). VEIEX has a lower initial minimum investment than BEMAX: VEIEX (0) vs BEMAX (2500). BEMAX annual gain was more profitable for investors over the last year : 26.61 vs. VEIEX (15.42). BEMAX return over 5 years is better than : 81.72 vs. VEIEX (39.14).
BEMAXVEIEXBEMAX / VEIEX
Total Expense Ratio1.320.29455%
Annual Report Gross Expense Ratio1.320.29455%
Fund Existence15 years31 years-
Gain YTD38.24724.249158%
Front Load6%N/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets835M130B1%
Annual Yield % from dividends2.382.6490%
Returns for 1 year26.6115.42173%
Returns for 3 years96.7752.73183%
Returns for 5 years81.7239.14209%
Returns for 10 years112.3584.00134%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNPR99.392.18
+2.24%
Monopar Therapeutics Inc
SUPN48.350.39
+0.81%
Supernus Pharmaceuticals
SGI84.240.28
+0.33%
Somnigroup International Inc.
ARTL4.69-0.13
-2.70%
Artelo Biosciences Inc
ZNTL1.61-0.05
-3.01%
Zentalis Pharmaceuticals